{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:19:19Z","timestamp":1771510759604,"version":"3.50.1"},"reference-count":15,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Emerging anticancer agents such as the pan-FGFR Inhibitor have achieved remarkable improvements in the survival of patients with metastatic malignancies. Nevertheless they are still associated with specific ophthalmic toxicities. Understanding their pathophysiology can lead us to better clinical practice of life-threatening and vision-threatening circumstances. To investigate choroidal alterations as a potential pathophysiological mechanism of a serous detachment in bilateral pan-FGFR Inhibitor-Associated Retinopathy (FGFRAR), the morphology of the choroid and choriocapillaris were assessed. The choroidal thickness (ChT) and choriocapillaris flow void were measured by macular optical coherence tomography (OCT) and angiography (OCT-A), respectively. Data were collected at the baseline, then at one-month and two-months follow-ups after starting erdafitinib, in a single case of pulmonary angiosarcoma. Choroidal and choriocapillaris morphology showed stable ChT and choriocapillaris flow void at FGFRAR onset and relapse. To the best of our knowledge, this is the first analyzed case reported with flow-void OCT-angiography. Considering these results, FGFRAR in this patient does not seem to match the pachychoroid spectrum disorder definition; rather, an intracellular mechanism based on intracellular transduction pathways may be at work.<\/jats:p>","DOI":"10.3390\/diagnostics12020249","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T22:40:20Z","timestamp":1642718420000},"page":"249","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Choroidal and Choriocapillaris Morphology in Pan-FGFR Inhibitor-Associated Retinopathy: A Case Report"],"prefix":"10.3390","volume":"12","author":[{"given":"Giuseppe","family":"Fasolino","sequence":"first","affiliation":[{"name":"Universitair Ziekenhuis Brussel, Brussels Health Campus, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-2062","authenticated-orcid":false,"given":"Laura","family":"Moschetta","sequence":"additional","affiliation":[{"name":"Universitair Ziekenhuis Brussel, Brussels Health Campus, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"De Gr\u00e8ve","sequence":"additional","affiliation":[{"name":"Universitair Ziekenhuis Brussel, Brussels Health Campus, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Nelis","sequence":"additional","affiliation":[{"name":"Universitair Ziekenhuis Brussel, Brussels Health Campus, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Lefesvre","sequence":"additional","affiliation":[{"name":"Universitair Ziekenhuis Brussel, Brussels Health Campus, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Ten Tusscher","sequence":"additional","affiliation":[{"name":"Universitair Ziekenhuis Brussel, Brussels Health Campus, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/IAE.0000000000001497","article-title":"Choriocapillaris signal voids in maternally inherited diabetes and deafness and in pseudoxanthoma elasticum","volume":"37","author":"Spaide","year":"2017","journal-title":"Retina"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajo.2016.07.023","article-title":"Choriocapillaris Flow Features Follow a Power Law Distribution: Implications for Characterization and Mechanisms of Disease Progression","volume":"170","author":"Spaide","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jamaophthalmol.2020.2778","article-title":"Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy","volume":"138","author":"Parikh","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"ref_4","first-page":"24741264211013629","article-title":"Fibroblast Growth Factor Receptor Inhibitor\u2013Associated Multifocal Serous Retinal Detachments: A Case Report","volume":"19","author":"Kim","year":"2021","journal-title":"J. Vitr. Dis."},{"key":"ref_5","first-page":"111","article-title":"Reversible Macular Lesions in the Setting of Oral Pan-Fibroblast Growth Factor Inhibitor for the Treatment of Bladder Cancer","volume":"2","author":"Prensky","year":"2018","journal-title":"J. Vitr. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/ceo.13940","article-title":"Increased interdigitation zone visibility on optical coherence tomography following systemic fibroblast growth factor receptor 1\u20133 tyrosine kinase inhibitor anticancer therapy","volume":"49","author":"Charng","year":"2021","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lee, M.W., Park, H.J., Shin, Y.I., Lee, W.H., Lim, H.B., and Kim, J.Y. (2020). Comparison of choroidal thickness measurements using swept source and spectral domain optical coherence tomography in pachychoroid diseases. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0229134"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: A review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_9","first-page":"e26","article-title":"Bilateral serous epithelial detachment after starting therapy with erdafitinib","volume":"61","author":"Sauerzopf","year":"2021","journal-title":"Consultant"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bjo.68.11.815","article-title":"Long-term follow-up of central serous chorioretinopathy","volume":"68","author":"Gilbert","year":"1984","journal-title":"Br. J. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1091\/mbc.9.10.2785","article-title":"Fibroblast growth factor (FGF) soluble receptor 1 acts as a natural inhibitor of FGF2 neurotrophic activity during retinal degeneration","volume":"9","author":"Guillonneau","year":"1998","journal-title":"Mol. Biol. Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ctrv.2013.01.003","article-title":"Effect of inhibition of the FGFR-MAPK signaling pathway on the development of ocular toxicities","volume":"39","author":"Leijen","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/08820538.2021.1903512","article-title":"Choriocapillaris Assessment in Patients Under Mek-Inhibitor Therapy For Cutaneous Melanoma: An Optical Coherence Tomography Angiography Study","volume":"36","author":"Fasolino","year":"2021","journal-title":"Semin. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40265-021-01507-z","article-title":"Ocular Toxicity of Targeted Anticancer Agents","volume":"81","author":"Fortes","year":"2021","journal-title":"Drugs"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Shin, E., Lim, D.H., Han, J., Nam, D.H., Park, K., Ahn, M.J., Kang, W.K., Lee, J., Ahn, J.S., and Lee, S. (2020). Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors. BMC Ophthalmol., 20.","DOI":"10.1186\/s12886-019-1285-9"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/2\/249\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:04:20Z","timestamp":1760133860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/2\/249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["diagnostics12020249"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12020249","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]}}}